| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8360d1b3d1eb0dea1ce85fb16a332d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72a57fffe587c6a2fad42266524b7445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_194c02641f7ec68ddfa3ebb60d0802c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6479b6ddd8f075e5b46d617370d88c64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77a1fe66bbef595d585fc63d36b6d52d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2299-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B20-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B15-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B20-30 |
| filingDate |
2004-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92cc7525dcd64d00237e61a4b3826641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_791d003c7bd12748980290b123b445ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_960a7c246da05fc13ac73fe1b76b12b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bfd8a0eb2223e808775e5652d8e09d3 |
| publicationDate |
2005-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005024013-A1 |
| titleOfInvention |
Masp-2 crystal structure and uses thereof |
| abstract |
The present invention relates to crystals of MASP-2 polypeptides and uses thereof. The disclosed MASP-2 crystals are useful for determining the 3-dimensional structure of MASP-2 polypeptides, including catalytically active MASP-2 polypeptides as well as zymogen MASP-2 polypeptides. As disclosed by the invention said 3-dimensional structure may be used for identifying compounds capable of interacting with and/or inhibiting the activity of MASP-2. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096676-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8652477-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7919094-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11008404-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8551790-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8785717-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11008405-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10660317-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8840893-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11225526-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9441262-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10189909-B2 |
| priorityDate |
2003-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |